Amplitude Venture Capital is an investment firm.
Business Model:
Revenue: $0
Employees: 0-0
Address: 3, Place Ville-Marie
City: Montreal
State: quebec
Zip: H3B 0E7
Country: CA
Amplitude Venture Capital deploys a growth model that has successfully been used to build Canadian companies with world-class management teams and scale companies to breakout potential. Since 2012 Amplitude&s;s founding team has raised over $700 million of equity capital in private and public markets. Amplitude, with offices in Montreal, Toronto, and Vancouver, launched its first private capital fund in November 2019, a $200-million fund that applies a proven, evidence-based approach to investing in leading Canadian precision medicine companies.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
4/2022 | DrugBank | Seed Round | 0 |
5/2021 | Giiant Pharma | Seed Round | 0 |
2/2021 | Notch Therapeutics | Series A | 85M |
12/2021 | Valence Discovery | Seed Round | 0 |
3/2022 | Celsius Therapeutics | Series B | 0 |
4/2023 | Evommune | Series B | 50M |
1/2022 | Gandeeva Therapeutics | Series A | 0 |
11/2019 | Milestone Pharmaceuticals | Post-IPO Equity | - |
11/2019 | Zymeworks | Post-IPO Equity | - |
4/2023 | Abdera Therapeutics | Series A | - |
1/2020 | Deep Genomics | Series B | 40M |
1/2018 | Shoebox Audiometry | Venture Round | - |
1/2018 | Imagia | Series A | 0 |
7/2021 | Deep Genomics | Series C | 0 |
8/2021 | Thryv Therapeutics | Series A | 0 |
4/2023 | Radiant Biotherapeutics | Seed Round | 0 |
11/2021 | Prilenia | Series B | 0 |
2/2022 | Congruence Therapeutics | Series A | 0 |
3/2023 | Congruence Therapeutics | Series A | 0 |
9/2019 | Repare Therapeutics | Series B | 82.5M |
9/2018 | PHEMI | Venture Round | 2.8M |
4/2023 | Radiant Biotherapeutics | Seed Round | 0 |
4/2023 | Abdera Therapeutics | Series A | - |
3/2023 | Congruence Therapeutics | Series A | 0 |
4/2022 | DrugBank | Seed Round | 0 |
3/2022 | Celsius Therapeutics | Series B | 0 |
2/2022 | Congruence Therapeutics | Series A | 0 |
1/2022 | Gandeeva Therapeutics | Series A | 0 |
12/2021 | Valence Discovery | Seed Round | 0 |
11/2021 | Prilenia | Series B | 0 |
8/2021 | Thryv Therapeutics | Series A | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|